Novel delivery method bypasses blood-brain barrier to treat ALS symptoms

A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral sclerosis (ALS), the neurodegenerative disorder commonly known as Lou Gehrig's disease. In a recent study, Mizzou's Smita Saxena showed that a natural molecule called GM1 can reach the brain when it's wrapped inside a tiny fat-based bubble. In early laboratory testing, this approach helped improve ALS symptoms.